A study of LX-101 in adults with IGF-1/IGF-1R enriched
Latest Information Update: 20 Mar 2024
At a glance
- Drugs LX 101 (Primary)
- Indications Cancer; Head and neck cancer
- Focus Adverse reactions
Most Recent Events
- 20 Mar 2024 New trial record
Latest Information Update: 20 Mar 2024